Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
about
Generation and biological activities of oxidized phospholipidsNF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells.Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivoEndothelial permeability is controlled by spatially defined cytoskeletal mechanics: atomic force microscopy force mapping of pulmonary endothelial monolayerSystems genetics analysis of gene-by-environment interactions in human cellsA role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrationsp190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury.Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipidsHydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function.Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholinep120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation.Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivoAssociation between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids.Afadin controls p120-catenin-ZO-1 interactions leading to endothelial barrier enhancement by oxidized phospholipids.Role of FAK in S1P-regulated endothelial permeability.Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids.WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.Endothelial cell regulation by phospholipid oxidation products.Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonateOxidized phospholipids in control of inflammation and endothelial barrier.Barrier enhancing signals in pulmonary edema.Loss of focal adhesion kinase enhances endothelial barrier function and increases focal adhesions.Control of vascular permeability by adhesion molecules.Lipid mediators in the regulation of endothelial barriers."RACK"-ing up the effectors: Receptor for activated C kinase acts downstream of Rac GTPase signaling in growth cone outgrowth.Structural motifs in primary oxidation products of palmitoyl-arachidonoyl-phosphatidylcholines by LC-MS/MS.Injured lung endothelium: mechanisms of self-repair and agonist-assisted recovery (2017 Grover Conference Series).
P2860
Q28389691-2464519F-7A55-4BD8-90A5-BD8899F77DE5Q28392832-4FC6E9B2-38CA-4204-9DA9-5F14A9DCAA84Q30441814-BD3486DA-2735-4B50-B685-F234491F0387Q33646887-D3545868-A00E-45C1-946B-E442B1B6E612Q33708619-7992715E-D3BA-4C08-BAD9-4C976845617EQ34150063-EF6B07AD-5450-41E6-9527-010B3B6502ECQ34671751-1FD919F2-B30B-4C96-920A-1190962963D0Q35067747-0C0F048C-B1C3-4C72-9B00-A5451A18863FQ35185343-682FBCA2-D4D2-4D9A-AB11-C5D8E8914FC1Q35387923-5D973ED7-C22F-48D6-BC5C-25E45DFADD79Q35889190-E25E9CB3-0326-40AE-90B5-E25F1D32A829Q36175619-BBE0287D-C72D-4EF9-A793-5BAFFBDA0C26Q36658987-19A45DA8-93E2-4695-B85C-8B11687CC882Q36840432-B1BA16D9-887C-4C6A-9244-D671B101BEEAQ36861923-FFBE9D2A-A36D-4567-B161-3467593CF4A2Q36933952-975187DC-5089-469D-97FB-6E007637B983Q36956209-21531E9B-8298-4BC0-BCFB-97B4623836E2Q36966966-5002B9DA-1361-4067-B677-1FF3270E4C36Q37156030-AAE9E841-8DFD-4CF9-A77F-3696250ABB76Q37274794-1653E5BE-B161-44B0-8138-F70037370AA0Q37420076-5027BD66-CD13-46E6-981C-AD29610C3A95Q38110515-253AB46D-3B2D-4169-9705-D1ADFE52D5C8Q39163831-A0BAB963-E387-4CB3-BE50-1AE3E2E1DA54Q41856569-368DC0B6-1D93-447D-87D1-753528E27084Q42517699-01E61266-80A8-4BF8-85C6-63FA17E70B36Q42760738-AD248DE0-632E-4E45-BBC4-B0C8AE26ED95Q43550910-CE377BA2-BAEC-47DF-9384-CC93E8023F9DQ52739219-0F119956-E923-44FA-ACE2-2BC6D7D1B75C
P2860
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
@ast
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
@en
type
label
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
@ast
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
@en
prefLabel
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
@ast
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
@en
P2093
P2860
P1476
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection
@en
P2093
Anna A Birukova
Konstantin G Birukov
Valery N Bochkov
P2860
P304
P356
10.1016/J.MVR.2006.12.004
P577
2007-01-03T00:00:00Z